PMC6925552_01
Patient psoriasis severity before treatment with Apremilast.
DMSO-12-2685-g0001.jpg
PMC6925552_01_DMSO-12-2685-g0001.jpg
F0001
Physical examination showed the presence of diffuse pink-red scaly plaques on the trunk, buttocks, periumbilical areas, dorsal hands and upper and lower extremities involving 30% body surface area, with a Psoriasis Area Severity Index score of 18 (Figure 1).
Patient psoriasis severity after 6 months of treatment with Apremilast.
DMSO-12-2685-g0002.jpg
PMC6925552_01_DMSO-12-2685-g0002.jpg
F0002
Apremilast 30 mg twice a day. After 6 months of treatment, he reached an almost complete resolution of his plaque psoriasis (PASI: 1) (Figure 2) with an improvement of the quality of life (DLQI:0) and no evident side effects.